INDV
Indivior Pharmaceuticals Inc · NASDAQ · Healthcare · USD · 10-K for 2025, filed 2026-02-26
Figures on this page computed 2026-11-08 12:32 UTC
Last close
36.28USD
Market data, 2026-11-02
Except where said otherwise: 10-K for 2025, filed 2026-02-26
21.6xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001628280-26-012237
- Reported in
- USD
- computed
- 10-K for 2025, filed 2026-02-26
396.9%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001628280-26-012237
- Reported in
- USD
- 10-K for 2025, filed 2026-02-26
- 10-K for 2025, filed 2026-02-26
- 10-K for 2025, filed 2026-02-26
- 10-Q for 2025, filed 2026-10-29
- 10-K for 2025, filed 2026-02-26
- 10-Q for 2025, filed 2026-10-29
16.9%Net margin
Net Income / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001628280-26-012237
- Reported in
- USD
- 10-K for 2025, filed 2026-02-26
- 10-K for 2025, filed 2026-02-26
-7.5%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001628280-26-012237
- Reported in
- USD
- 10-K for 2025, filed 2026-02-26
- 10-K for 2025, filed 2026-02-26
n/aDebt/equity
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001628280-26-012237
- Reported in
- USD
- 10-K for 2025, filed 2026-02-26
- 10-Q for 2025, filed 2026-10-29
n/aDividend yield
The stored value is a zero that stands for missing data rather than a measurement, so we will not place it.
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- USD
- computed
- Computed from the filing for 2016
Safety is the furthest below its sector's middle: 0.44 against 0.53 on the market's range.
- Growth13.9%82 of 100, above its sector
- Returns on capital396.9%98 of 100, above its sector
- Margins80.2%72 of 100, above its sector
- Price21.6x37 of 100, above its sector
- Safety0.7144 of 100, below its sector
- What it pays outn/anot placed
- What it pays out: n/aThe stored value is a zero that stands for missing data rather than a measurement, so we will not place it.
Five bars, one line
lens 7 of 9Each against its own average
5 of 5 readExcept where said otherwise: 10-K for 2025, filed 2026-02-26
- Sales1.27x
Its own average over 10 years, 972.1M.
- Profit3.53x
Its own average over 10 years, 59.6M.
- Free cash flow-1.24x
Its own average over 10 years, 74.9M.
- Debt1.01x
Its own average over 9 years, 347.9M.
- Price2.14x
Its own average over 11 years, 17. Market data, 2026-11-02
Profit is furthest from its own average, at 3.53 times.
Sales is 1.27 times its own 10-year average; Profit is 3.53 times its own 10-year average; Free cash flow is -1.24 times its own 10-year average; Debt is 1.01 times its own 9-year average; Price is 2.14 times its own 11-year average.
Every figure in this lens
Except where said otherwise: 10-K for 2025, filed 2026-02-26
Sales against its own 10-year average1.27
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001628280-26-012237
- Reported in
- USD
Profit against its own 10-year average3.53
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001628280-26-012237
- Reported in
- USD
Free cash flow against its own 10-year average-1.24
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001628280-26-012237
- Reported in
- USD
Debt against its own 9-year average1.01
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001628280-26-012237
- Reported in
- USD
Price against its own 11-year average2.14Market data, 2026-11-02
- Source
- market
- Taken on
- 2026-11-02
- Reported in
- USD